Researchers report several new direct acting antiviral, drugs commonly used to treat Hepatitis C, improve symptoms of PTSD.
Cannabidiol treatment helped reduce anxiety severity by, on average, 42.6% in young adults with treatment-resistant anxiety, a new study reports.
Researchers discuss how psychedelics can affect the brain and provide therapeutic benefits for those suffering from a range of psychiatric disorders.
Genetic variants of the 5-HT2A serotonin receptor may explain why some respond to psychedelic therapies for the treatment of mental health disorders while others don't.
Researchers explain why the serotonin hypothesis for depression may not be as accurate as previously believed.
Study reveals how reduced function of the rgs2 protein in the nucleus accumbens contributes to symptoms associated with depression. The findings may assist with the development of new therapeutics to help treat depression in individuals.
Researchers say pharmacogenomics can assist providers in determining the best antidepressant treatments for patients with depression and avoid prescribing medications that could have adverse effects.
Study reveals those who microdosed psilocybin for 30 days showed greater improvements in mood, mental health, and psychomotor abilities than those who did not microdose. The findings have positive implications for the use of psychedelics to help treat mental health disorders.
Study reveals a possible mechanism by which anxiolytic medications act on the brain, leading to cognitive impairment.
Researchers found no association between in vitro exposure to SSRI antidepressants and an increased risk of a child developing depression.
Probiotics can support the effects of antidepressants to help relieve symptoms of depression.
A new study will explore how psilocybin affects different networks and serotonin function in the brains of autistic adults.
